Last updated on March 2019

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis


Brief description of study

The purpose of this study is to evaluate the safety, tolerability, and efficacy of the combination of INCB050465 and ruxolitinib in subjects with myelofibrosis.

Clinical Study Identifier: NCT02718300

Find a site near you

Start Over

Keck School of Medicine of USC

Los Angeles, CA United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

St. Agnes Hospital

Baltimore, MD United States
  Connect »

Washington University

Saint Louis, MO United States
  Connect »

Summit Medical Group

Morristown, NJ United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Emory University

Atlanta, GA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.